期刊文献+

血小板活化因子与增龄及动脉粥样硬化性脑梗死相关研究 被引量:3

Study on relationship of platelet-activating factor with aging and atherosclerotic cerebral infarction
暂未订购
导出
摘要 目的研究血小板活化因子(PAF)与年龄及其动脉粥样硬化性脑梗死的关系.方法研究对象分别来自保健科健康普查、体检普通人群和脑梗死住院病人.采用放射免疫法检测普通人群不同年龄段组(20~29,30~39,40~49,50~59,60~69,70~79岁共6组),和动脉粥样硬化性脑梗死组(60~69岁)的血浆PAF水平.结果普通人群随着年龄的增加,血浆PAF水平呈现增高趋势,与年龄呈显著正相关(r = 0.3348,P< 0.01);在40~49岁年龄段组血浆PAF水平(388 ± 128)pg/ml已显著高于20~29年龄段组(338 ± 96)pg/ml,P= 0.034.动脉粥样硬化性脑梗死组血浆PAF值显著高于普通人群60~69同年龄段组[(504 ± 108)pg/ml vs (433 ± 103)pg/ml,P= 0.007].结论血PAF水平随年龄增加而升高,高血PAF可能是动脉粥样硬化性脑梗死的危险因素之一. Objective To explore the relationship between the levels of plasma platelet-activating factor and aging and atherosclerotic cerebral infarction. Methods The subjects were from the health mass investigation, physical examination population and cerebral infarction inpatients in healthcare department. Plasma PAF levels of different age groups (21~30, 31~40, 41~50, 51~60, 61~70, 71~80 years old, 6 groups) and atherosclerotic cerebral infarction group were determined by radioimmunoassay. Results With the aging, plasma PAF levels showed increasing trend, which had positive relationship to age (r= 0.334 8, P< 0.01). Plasma PAF levels in 41~50 years old group 〔(388± 128)pg/ml〕 were significantly higher than that (338± 96)pg/ml in 21~30 years old group (P=0.034). Plasma PAF concentrations in atherosclerotic cerebral infarction group were significantly higher than that in 61~70 years old group 〔(504 ± 108)pg/ml vs (433 ± 103)pg/ml, P=0.007〕. Conclusions With aging, plasma PAF increased. High plasma PAF could be one of risk factors of atherosclerotic cerebral infarction.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2005年第3期242-244,共3页 Chinese Journal of Gerontology
基金 深圳市科技基金资助项目(200204137)
关键词 血小板活化因子 增龄 脑梗死 动脉粥样硬化 Platelet-activating factor Aging Cerebral infarction Arteriosclerosis
  • 相关文献

参考文献12

  • 1Prescott SM, Zimmerman GA, Stafforini DM, et al . Platelet-activating factor and related lipid mediators[J]. Annu Rev Biochem,2000;69:419-45.
  • 2Tokumura A, Sumida T, Toujima M, et al . Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis[J]. Biofactors,2000;13(1-4):29-33.
  • 3Subbanagounder G, Leitinger N, Shih PT, et al . Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and in vivo inhibition by WEB 2086[J]. Circ Res,1999;85(4):311-8.
  • 4Loucks EB, Godin DV, Walley KR, et al . Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart[J]. Can J Cardiol,2003;19(3):267-74.
  • 5Aspey BS, Alp MS, Patel Y, et al . Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischaemia-an initial screening study[J]. Metab Brain Dis,1997;12(3):237-49.
  • 6Satoh K, Imaizumi T, Yoshida H, et al . Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke[J]. Acta Neurol Scand,1992;85(2):122-7.
  • 7Zimmerman GA, McIntyre TM, Prescott SM, et al . The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis[J]. Crit Care Med,2002;30(5 Suppl): S294-301.
  • 8Marathe GK, Zimmerman GA, Prescott SM, et al . Activation of vascular cells by PAF-like lipids in oxidized LDL[J]. Vascul Pharmacol,2002;38(4):193-200.
  • 9Kasapoglu M, Ozben T. Alterations of antioxidant enzymes and oxidative stress markers in aging[J]. Exp Gerontol,2001;36(2):209-20.
  • 10Grimble RF. Inflammatory response in the elderly[J]. Curr Opin Clin Nutr Metab Care,2003;6(1):21-9.

同被引文献12

  • 1方微,张慧信,王绿娅,武迎,秦彦文,王伟,杜兰平,刘斌.何首乌总苷对ApoE-/-小鼠动脉粥样硬化病变形成的影响[J].中国中药杂志,2005,30(19):1542-1545. 被引量:12
  • 2汪宁,刘青云,彭代银,戴敏,朱荃.通窍活血汤对脑缺血大鼠脑组织中CGRP、ET、IL-1β、TNF-α的影响[J].中成药,2005,27(11):1295-1297. 被引量:11
  • 3孙洪涛,顾成东,李刚,周同亮,张国强.血小板活化因子在心肌梗死患者中的水平变化[J].中国急救医学,2006,26(2):104-106. 被引量:5
  • 4杜杰.针刺治疗不射精症116例[J].河北中医,2007,29(4):338-338. 被引量:3
  • 5YAMADA Y,YASHIDA H,ICHIHARA S.et al.Correlation between plasma platelel-activating factor acelylhydrolase(PAF-AH)activity and PAF-AH genotypo,age,and atherosclerosis in a Japanese population[J].Atherosclerosis,2000,150(1):209-216.
  • 6NINIO E.Phospholipid mediators in the vessel wall:involvement in atherosclerosis[J].Curr opin Clin Nutr Metab Care,2005,8(2):123-131.
  • 7CARTER A M.Inflammation.thrombosis and acute coronary syndromes[J].Diab Vasc Dis Res,2005,2(3):113-121.
  • 8SUBBANAGOuNDER G,LEITINGER N.SHIN P T.et al.Evidence that phospholipid oxidation and/or platelet activating factor play an important role in early atherogenesis.In vitro and in vivo inhibition by WEB2086[J].Circ Res,1999,85(4):311-318.
  • 9Tokumura A. Sumida T. Toujima M. et al. Platelet-activating factor (PAF)-like oxidized phospholip ids:relevancc to athcrosclerosis. Bio- factors. 2000,13( 1-4) :29 - 33.
  • 10Subbanagounder G. Leitinger N. Shih Pt. et al. Evidence thar phospho- lipid oxidation products and/or platelet-activating factor play an impor- tant role in early atherogenesis: in vitro and in vivo inhibitionby- WEB2086. Circ Res. 1999,85(4) :311.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部